Daniel Desmond
Hematology & Oncology · Apo, AENPI 1063892214
Payments from drug & device makers
Across 69 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$206
- Karyopharm Therapeutics Inc.$155
- AstraZeneca$140
- Bristol Myers Squibb$92
- Gilead$92
- Incyte Corporation$89
- plus $790 from 20 others
What the payments were for
- Food & beverage$1,565100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 5 | $206 |
| Karyopharm Therapeutics Inc. | 7 | $155 |
| AstraZeneca(2 entities) | 7 | $140 |
| Bristol Myers Squibb | 4 | $92 |
| Gilead | 3 | $92 |
| Incyte Corporation | 5 | $89 |
| Exelixis Inc. | 4 | $86 |
| Sobi, Inc | 3 | $78 |
| Morphosys, US Inc. | 3 | $68 |
| Daiichi Sankyo Inc. | 4 | $62 |
| Amgen | 4 | $60 |
| Recordati_rare_diseases_inc. | 2 | $45 |
| G1 Therapeutics, Inc. | 2 | $44 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| Merck | 2 | $40 |
| GSK | 2 | $40 |
| Beigene USA, Inc. | 1 | $27 |
| Mirati Therapeutics, Inc. | 1 | $27 |
| ADC Therapeutics America, Inc. | 1 | $24 |
| AbbVie | 1 | $23 |
| Rigel Pharmaceuticals, Inc. | 1 | $23 |
| Coherus Oncology, Inc. | 1 | $23 |
| Stemline Therapeutics Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| CTI Biopharma Corp. | 1 | $19 |
| Pharmacosmos Therapeutics Inc. | 1 | $18 |
How this compares
Too few hematology & oncology providers in AEto place this figure against a meaningful peer group, so we don't.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.